Now on
Rare Partners supports the Istituto Italiano di Tecnologia (IIT) for the development of an innovative artificial retina
Rare Partners supports the IIT for the development of an innovative artificial retina
A new Orphan Drug Designation to Sirolimus
A new Orphan Drug Designation to Sirolimus
Rare Partners presents a poster on Thalassemia project
Rare Partners presents a poster on Thalassemia project.
US Patent Office has issued a patent covering the use of trimethylangelicin in Cystic Fibrosis
The United States Patent and Trademark Office has issued on March 15th the US Patent number 9283206 covering the use of trimethylangelicin (TMA) as CFTR Corrector in Bronchial Epithelial Cells.
Rare Partners Charity Partner at SuisseGas Milano Marathon 2016.
Rare Partners Charity Partner at SuisseGas Milano Marathon 2016.
Run4Usher, #runandimagetofly with us for Usher Syndrome.